222 related articles for article (PubMed ID: 35893907)
1. Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial.
De Niet S; Trémège M; Coffiner M; Rousseau AF; Calmes D; Frix AN; Gester F; Delvaux M; Dive AF; Guglielmi E; Henket M; Staderoli A; Maesen D; Louis R; Guiot J; Cavalier E
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893907
[TBL] [Abstract][Full Text] [Related]
2. Treatment With 25-Hydroxyvitamin D
Maghbooli Z; Sahraian MA; Jamalimoghadamsiahkali S; Asadi A; Zarei A; Zendehdel A; Varzandi T; Mohammadnabi S; Alijani N; Karimi M; Shirvani A; Holick MF
Endocr Pract; 2021 Dec; 27(12):1242-1251. PubMed ID: 34653608
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
[TBL] [Abstract][Full Text] [Related]
5. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
Annweiler C; Beaudenon M; Gautier J; Gonsard J; Boucher S; Chapelet G; Darsonval A; Fougère B; Guérin O; Houvet M; Ménager P; Roubaud-Baudron C; Tchalla A; Souberbielle JC; Riou J; Parot-Schinkel E; Célarier T;
PLoS Med; 2022 May; 19(5):e1003999. PubMed ID: 35639792
[TBL] [Abstract][Full Text] [Related]
6. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.
Sabico S; Enani MA; Sheshah E; Aljohani NJ; Aldisi DA; Alotaibi NH; Alshingetti N; Alomar SY; Alnaami AM; Amer OE; Hussain SD; Al-Daghri NM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202578
[TBL] [Abstract][Full Text] [Related]
7. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
[TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin D and magnesium supplementation on clinical symptoms and serum inflammatory and oxidative stress markers in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Ramezani-Jolfaie N; Eftekhar E; Dadinasab M; Hesarooeyeh ZG; Pakdaman P; Razmpour F; Javedan G; Khayatian M; Azad MH; Davoodian P; Brahimi E; Rafati S; Nikoofal-Sahlabadi S; Mohammadi M
Trials; 2023 Feb; 24(1):87. PubMed ID: 36747270
[TBL] [Abstract][Full Text] [Related]
11. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial.
Mariani J; Antonietti L; Tajer C; Ferder L; Inserra F; Sanchez Cunto M; Brosio D; Ross F; Zylberman M; López DE; Luna Hisano C; Maristany Batisda S; Pace G; Salvatore A; Hogrefe JF; Turela M; Gaido A; Rodera B; Banega E; Iglesias ME; Rzepeski M; Gomez Portillo JM; Bertelli M; Vilela A; Heffner L; Annetta VL; Moracho L; Carmona M; Melito G; Martínez MJ; Luna G; Vensentini N; Manucha W
PLoS One; 2022; 17(5):e0267918. PubMed ID: 35622854
[TBL] [Abstract][Full Text] [Related]
12. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.
Amrein K; Schnedl C; Holl A; Riedl R; Christopher KB; Pachler C; Urbanic Purkart T; Waltensdorfer A; Münch A; Warnkross H; Stojakovic T; Bisping E; Toller W; Smolle KH; Berghold A; Pieber TR; Dobnig H
JAMA; 2014 Oct; 312(15):1520-30. PubMed ID: 25268295
[TBL] [Abstract][Full Text] [Related]
13. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P
Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.
Amrein K; Sourij H; Wagner G; Holl A; Pieber TR; Smolle KH; Stojakovic T; Schnedl C; Dobnig H
Crit Care; 2011; 15(2):R104. PubMed ID: 21443793
[TBL] [Abstract][Full Text] [Related]
15. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.
Bassatne A; Basbous M; Chakhtoura M; El Zein O; Rahme M; El-Hajj Fuleihan G
Metabolism; 2021 Jun; 119():154753. PubMed ID: 33774074
[TBL] [Abstract][Full Text] [Related]
16. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
Beigmohammadi MT; Bitarafan S; Hoseindokht A; Abdollahi A; Amoozadeh L; Mahmoodi Ali Abadi M; Foroumandi M
Trials; 2020 Jul; 21(1):614. PubMed ID: 32631405
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation.
Mingiano C; Picchioni T; Cavati G; Pirrotta F; Calabrese M; Nuti R; Gonnelli S; Fortini A; Frediani B; Gennari L; Merlotti D
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571329
[TBL] [Abstract][Full Text] [Related]
18. COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial.
Annweiler C; Beaudenon M; Gautier J; Simon R; Dubée V; Gonsard J; Parot-Schinkel E;
Trials; 2020 Dec; 21(1):1031. PubMed ID: 33371905
[TBL] [Abstract][Full Text] [Related]
19. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
